Clinical trial
Monitoring and Evaluation of the Therapeutic Efficacy and Safety of Pyronaridine-artesunate for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia, an Area of Artemisinin-resistant Falciparum Malaria
NCT02389439 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Monitoring and Evaluation of the Therapeutic Efficacy and Safety of Pyronaridine-artesunate for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia, an Area of Artemisinin-resistant Falciparum Malaria
- Lead sponsor
- University of Oxford
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 1, 2015
- Completion date
- June 1, 2016
- Enrollment
- 123 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.